Jubilant Life has target of Rs 183.50: Ashish Tater

Published on Tue, Jun 28, 2011 at 13:49 |  Source : CNBC-TV18

Updated at Tue, Jun 28, 2011 at 14:29  

4197 Investors following Jubilant Life. Share this News with them.
0
0
Share on Tumblr
Jubilant Life has target of Rs 183.50: Ashish Tater

ALSO READ

Jubilant Life Sciences has intraday target of Rs 183.50, says Ashish Tater, Fort Share Broking

Tater told CNBC-TV18, "Jubilant Life Sciences is undervalued by atleast 20% at current levels and we have a medium-term target of close to Rs 210 mark. Looking its business into Osteoporosis and others, this particular stock is definitely to get rerating and I have an intermediate target of close to Rs 210 mark and intraday target of close to Rs 183.50.

Click HERE to know the rules and follow the score card

  

Trending News

Business News

Download Windows 8 Release Preview for free now
Will India's millionaire homes affect property prices for aam aadmi? "Will India's millionaire homes affect property prices for aam aadmi? "

Ranvir Sena chief killed, Bihar on high alert

Fitch Revises Indian Bank Outlook To Negative; Affirms BBB-

The latest earning numbers FIRST on CNBC-TV18
Videos

Jun 1 2012, 14:57

Delisting candidates are risky; be cautious: SMC

- in MARKET OUTLOOK

Jun 1 2012, 11:57

Raamdeo Agrawal lauds Q4 nos, sees drastic rate cuts ahead

- in MARKET OUTLOOK

Interviews

Jun 1 2012, 15:36 | Source: CNBC-TV18

M&M performed well on strategy, not fuel prices: Nayer  

Jun 1 2012, 11:29 | Source: CNBC-TV18

HDIL eyes revenues of Rs 2500 cr in FY13  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!